Interferon-alpha enhances the antitumour activity of EGFR-targeted therapies by upregulating RIG-I in head and neck squamous cell carcinomaHailong Ma, Jingzhou Hu, Mei Zhao et al.|British Journal of Cancer|2018Cited by 42